FIELD: medicine.
SUBSTANCE: invention represents a drug preparation for treating diseases caused by type 1 herpes simplex and cytomegalovirus, containing recombinant human interferon 2α, lisocyme, Licopid, carnitine 20%, vitamin E and a fatty base.
EFFECT: higher clinical effectiveness and reduced length of treatment, prolonged intercurrent periods, lower recurrent rate by prophylactic administration, reduced manifestation of neurotoxic effects of herpes viruses, lower administration of antibiotics for preventing bacterial complications in infectious-inflammatory diseases caused by herpes simplex virus and cytomegalovirus in children.
2 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIFUNGAL THERAPEUTIC PREPARATION IN SUPPOSITORIES FOR CHILDREN | 2013 |
|
RU2535068C1 |
DRUG AND METHOD OF TREATING INFECTIOUS AND INFLAMMATORY DISEASES | 2009 |
|
RU2414927C1 |
METHOD FOR TREATING ACUTE HEPRETIC STOMATITIS IN CHILDREN | 2011 |
|
RU2444372C1 |
IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
METHOD FOR TREATING RECURRENT HERPETIC STOMATITIS CASES AGGRAVATED BY SOMATOPHOROUS PAIN DISORDER | 2005 |
|
RU2304971C2 |
METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS | 2008 |
|
RU2391981C2 |
METHOD FOR TREATMENT OF HERPES HEPATITIS | 2009 |
|
RU2441646C2 |
METHOD FOR IMMUNOTHERAPY OF CHRONIC REFRACTORY HERPES VIRUS INFECTION | 2011 |
|
RU2485962C1 |
HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
METHOD OF TREATING AFFECTION OF VEGETATIVE PARASYMPATHETIC NODES OF HEAD OF HERPES-VIRUS ETIOLOGY | 2013 |
|
RU2538083C1 |
Authors
Dates
2014-06-27—Published
2013-03-19—Filed